Trial intelligence / Profile preview

Avapritinib in indolent systemic mastocytosis with inadequate symptom control

NL-OMON52372Phase 2Recruiting

Sponsor

Blueprint Medicines

Start

May 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1